Literature DB >> 26424747

Prognostic Indicators for Salvage Surgery of Recurrent Sinonasal Malignancy.

Daniel James Kaplan1, Jee Hong Kim2, Eric Wang3, Carl Snyderman3.   

Abstract

OBJECTIVE: Identify prognostic factors after salvage surgery for recurrent sinonasal malignancy (SNM). STUDY
DESIGN: Case series with chart review.
SETTING: University of Pittsburgh Medical Center.
SUBJECTS: Forty-two patients who underwent curative surgery for locally recurrent SNM ± adjuvant therapy from June 5, 2000, to December 19, 2012. Patients without follow-up were excluded.
METHODS: Chart review with established prognostic indicators for primary malignancies. Statistical analysis included Kaplan-Meier log-rank test, Fisher's exact test, Student's t test, and Cox regression.
RESULTS: Forty-two patients met inclusion criteria: 38.5% developed a second recurrence, and 21.4% had metastases following treatment. The average disease-free interval (DFI) was 26.9 months (range, 2-90 months). DFI was significantly affected by ethmoid versus nonethmoid site (P = .049), histology (P = .012), carotid artery involvement (P = .008), perineural extension (P = .006), and clival invasion (P = .015). The overall survival rates at 6 months, 12 months, and 5 years following surgery were 83.3%, 69%, and 47.6%, respectively. Survival was affected by histology (P = .014), stratified grade (P = .042), tumor extension into the orbit (P = .019), carotid artery (P = .001), perineural space (P = .028), and clivus (P = .022). Complications occurred in 28.6% of patients and were associated with histology (P = .04). Length of hospital stay related to treatment was affected by histology (P = .009), grade (P = .013), and postoperative complication (P < .001). The median percentage of time hospitalized was 8%, and 43% of patients who died within 12 months spent >10% of their remaining days in the hospital.
CONCLUSION: High-risk histologic subtype (melanoma, sinonasal undifferentiated carcinoma, adenocarcinoma, neuroendocrine cancer, sarcoma, and squamous cell carcinoma), grade, and orbital and skull base involvement negatively affect survival and/or DFI for patients with local recurrence of SNM. Improved stratification of patients can be used to guide decision making for patients with recurrent SNM and to avoid inappropriate surgery. © American Academy of Otolaryngology-Head and Neck Surgery Foundation 2015.

Entities:  

Keywords:  prognostic indicators; recurrent sinonasal malignancy; recurrent sinonasal prognosis; treatment algorithm

Mesh:

Year:  2015        PMID: 26424747     DOI: 10.1177/0194599815606699

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  2 in total

Review 1.  The Selective Role of Open and Endoscopic Approaches for Sinonasal Malignant Tumours.

Authors:  Fernando López; Jatin P Shah; Jonathan J Beitler; Carl H Snyderman; Valerie Lund; Cesare Piazza; Antti A Mäkitie; Orlando Guntinas-Lichius; Juan P Rodrigo; Luiz P Kowalski; Miquel Quer; Ashok Shaha; Akihiro Homma; Alvaro Sanabria; Renata Ferrarotto; Anne W M Lee; Victor H F Lee; Alessandra Rinaldo; Alfio Ferlito
Journal:  Adv Ther       Date:  2022-03-30       Impact factor: 4.070

2.  Salvage surgery in recurrent sinonasal cancers: Proposal for a prognostic model based on clinicopathologic and treatment-related parameters.

Authors:  Davide Mattavelli; Michele Tomasoni; Marco Ferrari; Alessandra Compagnoni; Alberto Schreiber; Stefano Taboni; Vittorio Rampinelli; Elisa Marazzi; Elena Raffetti; Luca Oscar Redaelli de Zinis; Alberto Deganello; Roberto Maroldi; Paolo Bossi; Cesare Piazza; Piero Nicolai
Journal:  Head Neck       Date:  2022-06-02       Impact factor: 3.821

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.